{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,7]],"date-time":"2024-02-07T17:09:30Z","timestamp":1707325770030},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1996,5,1]],"date-time":"1996-05-01T00:00:00Z","timestamp":830908800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[1996,5]]},"DOI":"10.1007\/bf01682343","type":"journal-article","created":{"date-parts":[[2005,5,13]],"date-time":"2005-05-13T17:29:35Z","timestamp":1116005375000},"page":"213-217","source":"Crossref","is-referenced-by-count":15,"title":["The role of bisphosphonates in the treatment of bone metastases \u2014 the U.S. experience"],"prefix":"10.1007","volume":"4","author":[{"given":"Harold A.","family":"Harvey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allan","family":"Lipton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF01682343_CR1","first-page":"418","volume":"7","author":"JA Albright","year":"1986","unstructured":"Albright JA, Gillespie TE, Butaud TR (1986) Treatment of bone metastases. Semin Oncol 7:418\u2013434","journal-title":"Semin Oncol"},{"key":"BF01682343_CR2","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.1002\/1097-0142(19931201)72:11+<3443::AID-CNCR2820721611>3.0.CO;2-3","volume":"72","author":"SD Averbuch","year":"1993","unstructured":"Averbuch SD (1993) New bisphosphonates in the treatment of bone metastases. Cancer 72:3443\u20133452","journal-title":"Cancer"},{"key":"BF01682343_CR3","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1097\/00001622-199208000-00005","volume":"4","author":"JJ Body","year":"1992","unstructured":"Body JJ (1992) Bone metastases and tumor-induced hypercalcemia. Current Opin Oncol 4:624\u2013631","journal-title":"Current Opin Oncol"},{"key":"BF01682343_CR4","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/BF01697625","volume":"66","author":"MR Clemens","year":"1993","unstructured":"Clemens MR, Fessele K, Heim ME (1993) Multiple myeloma: effect of daily dichloromethylene bisphosphonate on skeletal complications. Ann Hematol 66:141\u2013146","journal-title":"Ann Hematol"},{"key":"BF01682343_CR5","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1136\/bmj.309.6963.1233b","volume":"309","author":"RE Coleman","year":"1994","unstructured":"Coleman RE (1994) Therapeutic use of bisphosphonates in oncology. BMJ 309:1233","journal-title":"BMJ"},{"key":"BF01682343_CR6","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0305-7372(93)90028-P","volume":"19","author":"RE Coleman","year":"1993","unstructured":"Coleman RE, Purohit OP (1993) Osteoclast inhibition for the treatment of bone metastases. Cancer Treat Rev 19:79\u2013103","journal-title":"Cancer Treat Rev"},{"key":"BF01682343_CR7","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0305-7372(85)90008-8","volume":"12","author":"RE Coleman","year":"1985","unstructured":"Coleman RE, Rubens RD (1985) Bone metastases and breast cancer. Cancer Treat Rev 12:251\u2013270","journal-title":"Cancer Treat Rev"},{"key":"BF01682343_CR8","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/bjc.1987.13","volume":"55","author":"RE Coleman","year":"1987","unstructured":"Coleman RE, Rubens RD (1987) The clinical course of bone metastases in breast cancer. Br J Cancer 55:61\u201366","journal-title":"Br J Cancer"},{"issue":"Suppl 7","key":"BF01682343_CR9","first-page":"S41","volume":"5","author":"PF Conte","year":"1994","unstructured":"Conte PF, Giannessi PG, Latreille J, Mauriac L, Koliren L, Calabresi F, Ford JM (1994) Delayed progression of bone metastases with pamidronate therapy in breast cancer patients: a randomized muticenter phase III trial. Ann Oncol 5 [Suppl 7]:S41\u201344","journal-title":"Ann Oncol"},{"key":"BF01682343_CR10","first-page":"118","volume":"10","author":"RA Coyler","year":"1986","unstructured":"Coyler RA (1986) Surgical stabilization of pathologic neoplastic fractures. Curr Probl Cancer 10:118\u2013168","journal-title":"Curr Probl Cancer"},{"key":"BF01682343_CR11","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1200\/JCO.1992.10.4.591","volume":"10","author":"G Francini","year":"1992","unstructured":"Francini G, Gonnelli S, Petrioli R, Conti F, Paffetti P, Gennari C (1992) Treatment of bone metastases with dichloromethylene bisphosphonate. J Clin Oncol 10:591\u2013598","journal-title":"J Clin Oncol"},{"key":"BF01682343_CR12","first-page":"20","volume":"169","author":"CSB Galasko","year":"1982","unstructured":"Galasko CSB (1982) Mechanisms of lytic and blastic metastatic disease of bone. Clin Orthop 169:20\u201327","journal-title":"Clin Orthop"},{"key":"BF01682343_CR13","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1002\/1097-0142(19941201)74:11<2949::AID-CNCR2820741110>3.0.CO;2-Q","volume":"74","author":"D Glover","year":"1994","unstructured":"Glover D, Lipton A, Keller A, Miller AA, Browning S, Fram RJ, George S, Zelenakas K, Macerata RS, Seaman JJ (1994) Intravenous pamidronate disodium treatment of bone metastases in patients with breast cancer. A dose-seeking study. Cancer 74:2949\u20132955","journal-title":"Cancer"},{"key":"BF01682343_CR14","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1002\/jbmr.5650090521","volume":"9","author":"JR Green","year":"1994","unstructured":"Green JR, Muller K, Jaeggi KA (1994) Preclinical pharmacology of CGP 42'446, a new, potent, heterocyclic bisphosphonate compound. J Bone Miner Res 9:745\u2013751","journal-title":"J Bone Miner Res"},{"key":"BF01682343_CR15","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/0277-5379(91)90212-V","volume":"27","author":"AT Holten-Verzantvoort van","year":"1991","unstructured":"Holten-Verzantvoort AT van, Zwinderman AH, Aaronson NK, Hermans J, Emmerik B van, Dam FS van, Bos B van den, Bijvoet OL, Cleton FJ (1991) The effect of supportive pamidronate treatment on aspects of quality of life of patients with advanced breast cancer. Eur J Cancer 27:544\u2013549","journal-title":"Eur J Cancer"},{"key":"BF01682343_CR16","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1200\/JCO.1993.11.3.491","volume":"11","author":"AT Holten-Verzantvoort van","year":"1993","unstructured":"Holten-Verzantvoort AT van, Kroon HM, Bijvoet OL, Cleton FJ, Beex LV, Blijham G, Hermans J, Neijt JP, Papapoulos SE, Sleeboom HP, et al (1993) Palliative pamidronate treatment in patients with bone metastases from breast cancer. J Clin Oncol 11:491\u2013498","journal-title":"J Clin Oncol"},{"key":"BF01682343_CR17","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/1097-0142(19840201)53:3<577::AID-CNCR2820530335>3.0.CO;2-U","volume":"53","author":"GN Hortobagyi","year":"1984","unstructured":"Hortobagyi GN, Libshitz HI, Seabold JE (1984) Osseous metastases of breast cancer. Clinical, biochemical, radiographic and scintigraphic evaluation of response to therapy. Cancer 53:577\u2013582","journal-title":"Cancer"},{"issue":"Suppl 7","key":"BF01682343_CR18","first-page":"S25","volume":"5","author":"A Lipton","year":"1994","unstructured":"Lipton A (1994) The role of pamidronate. Ann Oncol 5 [Suppl 7]:S25\u201326","journal-title":"Ann Oncol"},{"issue":"Suppl 7","key":"BF01682343_CR19","first-page":"31","volume":"5","author":"A Lipton","year":"1994","unstructured":"Lipton A, Glover D, Harvey H, Grabelsky S, Zelenakas K, Macerata R, Seaman J (1994) Pamidronate in the treatment of bone metastases: results of 2 dose-ranging trials in patients with breast or prostate cancer. Ann Oncol 5 [Suppl 7]: S31\u201335","journal-title":"Ann Oncol"},{"key":"BF01682343_CR20","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1159\/000226904","volume":"48","author":"A Martoni","year":"1991","unstructured":"Martoni A, Guaraldi M, Camera P, Biagi R, Marri S, Beghe F, Pannuti F (1991) Controlled clinical study on the use of dichloromethylene diphosphonate in patients with breast carcinoma metastasizing to the skeleton. Oncology 48:97\u2013101","journal-title":"Oncology"},{"key":"BF01682343_CR21","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0960-0760(92)90197-Q","volume":"43","author":"SE Papapoulos","year":"1992","unstructured":"Papapoulos SE, Holten-Verzantvoort AT van (1992) Modulation of tumour-induced bone resorption by bisphosphonates. J Steroid Biochem Mol Biol 43:131\u2013136","journal-title":"J Steroid Biochem Mol Biol"},{"key":"BF01682343_CR22","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1200\/JCO.1993.11.1.59","volume":"11","author":"AH Paterson","year":"1993","unstructured":"Paterson AH, Powles TJ, Kanis JA, McCloskey E, Hanson J, Ashley S (1993) Double-blind controlled trial of oral clodronate in patients with bone metastases from breast cancer. J Clin Oncol 11:59\u201365","journal-title":"J Clin Oncol"},{"key":"BF01682343_CR23","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0889-8588(18)30193-X","volume":"8","author":"CL Shapiro","year":"1994","unstructured":"Shapiro CL (1994) Bisphosphonates in breast cancer patients with skeletal metastases. Hematol Oncol Clin North Am 8:153\u2013163","journal-title":"Hematol Oncol Clin North Am"},{"key":"BF01682343_CR24","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0277-5379(91)90056-J","volume":"27","author":"D Thiebaud","year":"1991","unstructured":"Thiebaud D, Leyvraz S, Fliedner V von, Perey L, Cornu P, Thiebaud S, Burckhardt P (1991) Treatment of bone metastases from breast cancer and myeloma with pamidronate. Eur J Cancer 27:37\u201341","journal-title":"Eur J Cancer"},{"issue":"Suppl 7","key":"BF01682343_CR25","first-page":"545","volume":"5","author":"B Thurlimann","year":"1994","unstructured":"Thurlimann B (1994) Progress in the treatment and palliation of advanced breast cancer: does the dose of pamidronate determine its effects? Ann Oncol 5 [Suppl 7]:545\u2013547","journal-title":"Ann Oncol"},{"issue":"Suppl 7","key":"BF01682343_CR26","first-page":"27","volume":"5","author":"CJ Tyrell","year":"1994","unstructured":"Tyrell CJ, Collinson M, Madsen EL, Ford JM, Coleman T (1994) Intravenous pamidronate: infusion rate and safety. Ann Oncol 5 [Suppl 7]: S27\u201329","journal-title":"Ann Oncol"},{"key":"BF01682343_CR27","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0140-6736(93)90037-H","volume":"341","author":"HS Wasan","year":"1993","unstructured":"Wasan HS, Waxman J (1993) Clodronate for multiple myeloma. Lancet 341:175\u2013176","journal-title":"Lancet"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01682343.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01682343\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01682343","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T11:15:41Z","timestamp":1557314141000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01682343"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,5]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1996,5]]}},"alternative-id":["BF01682343"],"URL":"https:\/\/doi.org\/10.1007\/bf01682343","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,5]]}}}